Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial

Background Although pancreatic duct guidewire placement (P-GW) for achieving selective biliary cannulation is reported to be effective in patients in whom endoscopic retrograde cholangiopancreatography (ERCP) is difficult, this technique entails a possible increased risk of post-ERCP pancreatitis. W...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology Vol. 45; no. 11; pp. 1183 - 1191
Main Authors Ito, Kei, Fujita, Naotaka, Noda, Yutaka, Kobayashi, Go, Obana, Takashi, Horaguchi, Jun, Takasawa, Osamu, Koshita, Shinsuke, Kanno, Yoshihide, Ogawa, Takahisa
Format Journal Article
LanguageEnglish
Published Japan Japan : Springer Japan 01.11.2010
Springer Japan
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0944-1174
1435-5922
1435-5922
DOI10.1007/s00535-010-0268-7

Cover

More Information
Summary:Background Although pancreatic duct guidewire placement (P-GW) for achieving selective biliary cannulation is reported to be effective in patients in whom endoscopic retrograde cholangiopancreatography (ERCP) is difficult, this technique entails a possible increased risk of post-ERCP pancreatitis. We conducted a prospective randomized controlled trial to evaluate the prophylactic effect of pancreatic duct stenting on the frequency of post-ERCP pancreatitis in patients who underwent P-GW. Methods Seventy patients who underwent P-GW for achieving selective biliary cannulation were included in this study. Patients were randomly assigned to either the stent group (n = 35) or the no-stent group (n = 35). The pancreatic duct stent used was a 5-Fr, 4-cm-long stent with a single pigtail at the duodenal end (Pit-stent™). The primary endpoint was the frequency of post-ERCP pancreatitis. Results Selective biliary cannulation was achieved in 80% of the stent group and in 94% of the no-stent group (P = 0.15). Post-ERCP pancreatitis occurred in 13% (9 patients; mild). Pancreatic duct stenting was successful in 91% of the stent group. One patient in the stent group developed migration of the stent during the procedure, followed by mild pancreatitis. The frequency of post-ERCP pancreatitis in the stent group was significantly lower than that in the no-stent group (2.9 vs. 23%, relative risk 0.13, confidence interval 0.016, 0.95). Conclusion Pancreatic duct stenting after P-GW for achieving selective biliary cannulation is recommended to reduce the incidence of post-ERCP pancreatitis.
Bibliography:http://dx.doi.org/10.1007/s00535-010-0268-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0944-1174
1435-5922
1435-5922
DOI:10.1007/s00535-010-0268-7